Skip to main content

Table 3 QoL by haemostatic interventions of patients that underwent surgery after a femur fracture

From: Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery

 

Control

n = 46

mean (SD)

FG

n = 46

mean (SD)

Topical TXA

n = 42

mean (SD)

All patients

N = 134

mean (SD)

p

EQVAS

 Baseline

66.3 (16.2)

69.4 (18.4)

70.6 (13.6)

68.6 (16.2)

0.517

 Pre-surgical

32.1 (11.0)

31.3 (14.2)

29.1 (11.8)

30.9 (12.6)

0.512

 Post-surgical

41.8 (16.8)

43.9 (15.3)

43.4 12.9)

43.0 (15.1)

0.782

 1 month

54.4 (21.7)

56.2 (16.6)

55.9 (15.9)

55.5 (18.2)

0.889

 6 months

52.9 (24.6)

58.6 (15.9)

61.7 (15.5)

57.7 (19.0)

0.980

 12 months

51.2 (26.9)

58.0 (19.9)

63.1 (18.8)

57.1 (22.6)

0.045

EQ5D5L index

 Baseline

0.634 (0.229)

0.689 (0.317)

0.714 (0.268)

0.676 (0.272)

0.456

 Pre-surgical

-0.390 (0.227)

-0.317 (0.323)

-0.447 (0.174)

-0.383 (0.255)

0.054

 Post-surgical

0.104 (0.277)

0.221 (0.244)

0.139 (0.286)

0.155 (0.271)

0.103

 1 month

0.355 (0.353)

0.443 (0.297)

0.400 (0.351)

0.399 (0.333)

0.459

 6 months

0.442 (0.374)

0.533 (0.366)

0.593 (0.312)

0.520 (0.356)

0.133

 12 months

0.435 (0.383)

0.529 (0.417)

0.626 (0.306)

0.527 (0.379)

0.059

  1. TXA Tranexamic Acid, FG Fibrin Glue, VAS Visual Analogical Scale